SNSE Archived Articles
Sensei Biotherapeutics (NASDAQ:SNSE) - Pioneering the Next Generation of Cancer Immunotherapies</startoftitle>
Published on March 14, 2025
Sensei Biotherapeutics (SNSE): A Clinical-Stage Immuno-Oncology Pioneer With a Promising Pipeline
Published on November 30, 2024
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Advancing Novel Immuno-Oncology Therapies with Promising Pipeline
Published on September 24, 2024